Cargando…

miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models

Mostrar otras versiones (1)

Palbociclib is in early-stage clinical testing in advanced hepatocellular carcinoma (HCC). Here, we investigated whether the anti-tumor activity of palbociclib, which prevents the CDK4/6-mediated phosphorylation of RB1 but simultaneously activates AKT signaling, could be improved by its combination...

Descripción completa

Detalles Bibliográficos
Autores principales:	Callegari, Elisa, Guerriero, Paola, Bassi, Cristian, D’Abundo, Lucilla, Frassoldati, Antonio, Simoni, Edi, Astolfi, Laura, Silini, Enrico Maria, Sabbioni, Silvia, Negrini, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395755/ https://www.ncbi.nlm.nih.gov/pubmed/36035756 http://dx.doi.org/10.1016/j.omtn.2022.07.015

Ejemplares similares

miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
por: Callegari, Elisa, et al.
Publicado: (2022)

miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model
por: Callegari, Elisa, et al.
Publicado: (2018)

Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus
por: Callegari, Elisa, et al.
Publicado: (2013)

Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2014)

miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eμ-TCL1 mouse model
por: Bresin, Antonella, et al.
Publicado: (2015)

miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs
por: Lupini, Laura, et al.
Publicado: (2013)

MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
por: Callegari, Elisa, et al.
Publicado: (2018)

miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression
por: Ferracin, Manuela, et al.
Publicado: (2013)

Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with “Oncogene-Addicted” Advanced Lung Adenocarcinoma: A Real-World Clinical Study
por: Lupini, Laura, et al.
Publicado: (2022)

Novel Virus Identification through Metagenomics: A Systematic Review
por: Bassi, Cristian, et al.
Publicado: (2022)

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2018)

Role of microRNAs in hepatocellular carcinoma: a clinical perspective
por: Callegari, Elisa, et al.
Publicado: (2013)

A comprehensive approach for microbiota and health monitoring in mouse colonies using metagenomic shotgun sequencing
por: Scavizzi, Ferdinando, et al.
Publicado: (2021)

Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing
por: Lupini, Laura, et al.
Publicado: (2022)

Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer
por: Roncarati, Roberta, et al.
Publicado: (2020)

Animal Models of Hepatocellular Carcinoma Prevention
por: Shankaraiah, Ram C., et al.
Publicado: (2019)

Palbociclib Promotes Dephosphorylation of NPM/B23 at Threonine 199 and Inhibits Endometrial Cancer Cell Growth
por: Lin, Chiao-Yun, et al.
Publicado: (2019)

Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma
por: Lupini, Laura, et al.
Publicado: (2016)

miR-199a and miR-199b facilitate diffuse gastric cancer progression by targeting Frizzled-6
por: Hong, Soon Auck, et al.
Publicado: (2023)

TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
por: Bresin, A, et al.
Publicado: (2016)

MicroRNA involvement in hepatocellular carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2008)

High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy
por: Lupini, Laura, et al.
Publicado: (2018)

Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis
por: He, Jun, et al.
Publicado: (2013)

Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis
por: Zeng, Ni, et al.
Publicado: (2021)

Expression of MiR-140 and MiR-199 in Synovia and its Correlation with the Progression of Knee Osteoarthritis
por: Chao, Yu, et al.
Publicado: (2020)

Association of H-Type Hypertension with miR-21, miR-29, and miR-199 in Kazahks of Xinjiang, China
por: He, Xin, et al.
Publicado: (2022)

Identification of miR-199-5p and miR-199-3p Target Genes: Paxillin Facilities Cancer Cell Aggressiveness in Head and Neck Squamous Cell Carcinoma
por: Tanaka, Nozomi, et al.
Publicado: (2021)

The Progression of Liver Fibrosis Is Related with Overexpression of the miR-199 and 200 Families
por: Murakami, Yoshiki, et al.
Publicado: (2011)

Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer
por: Gianni, Luca, et al.
Publicado: (2022)

How Infant and Toddlers’ Media Use Is Related to Sleeping Habits in Everyday Life in Italy
por: Bellagamba, Francesca, et al.
Publicado: (2021)

Understanding organizational perspectives from clinical research stakeholders involved in recruitment for biopharmaceutical-sponsored clinical trials in the United States: Recommendations for organizational initiatives to improve access and inclusivity in clinical research
por: Johnson, Rebecca R., et al.
Publicado: (2023)

miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma
por: Minna, Emanuela, et al.
Publicado: (2014)

Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma
por: Torres, Anna, et al.
Publicado: (2012)

miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators
por: Wang, Peipei, et al.
Publicado: (2015)

Twist-1 regulates the miR-199a/214 cluster during development
por: Lee, Youn-Bok, et al.
Publicado: (2009)

MiR-199a Regulates Cell Proliferation and Survival by Targeting FZD7
por: Song, Jiugang, et al.
Publicado: (2014)

MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b
por: Yu, Yangsheng, et al.
Publicado: (2022)

The role of AURKA/miR‐199b‐3p in hepatocellular carcinoma cells
por: Li, Guogang, et al.
Publicado: (2022)

Expression Profile of miR-199a and Its Role in the Regulation of Intestinal Inflammation
por: Wu, Zijuan, et al.
Publicado: (2023)

The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma
por: Crudele, Francesca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eqr104tor224ma39q05461ge4o